Once-Weekly Insulin Icodec vs . Once-Daily Insulin Glargine U100 for type 2 diabetes: a systematic review and meta-analysis of phase 2 randomized controlled trials.

Rodrigo Ribeiro E Silva,Mateus de Miranda Gauza,Maria Eduarda Schramm Guisso,Júlia Opolski Nunes da Silva, Suely Keiko Kohara

Archives of endocrinology and metabolism（2023）

引用 3|浏览0

暂无评分

摘要

OnceWeekly Insulin Icodec was associated with a small reduction in Glycated Hemoglobin, as well as higher Time with Glucose in Range, with similar hypoglycemic adverse events, when compared with Once-Daily Insulin Glargine U100.

查看译文

关键词

insulin,diabetes,randomized controlled trials,once-weekly,once-daily,meta-analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要